Intra-Sana Laboratories
Intra-Sana Laboratories is focused on the commercialization of FDA-approved pharmaceutical products for the prevention and/or treatment of gastrointestinal disorders and conditions. They work closely with independent and specialty pharmacies, aiming to provide innovative solutions for healthcare providers and patients.
Industries
Nr. of Employees
medium (51-250)
Intra-Sana Laboratories
7455 Arroyo Crossing Suite 220, Las Vegas, NV 89113
Products
Glycopyrrolate tablets (1.5 mg, oral)
FDA-approved oral glycopyrrolate tablets offered as a prescription option intended for treatment of peptic ulcer disease (PUD) as an alternative therapeutic option.
Ursodiol capsules (oral)
FDA-approved ursodiol capsules provided as prescription therapy with dosage options for prevention and treatment of gallstones.
Glycopyrrolate tablets (1.5 mg, oral)
FDA-approved oral glycopyrrolate tablets offered as a prescription option intended for treatment of peptic ulcer disease (PUD) as an alternative therapeutic option.
Ursodiol capsules (oral)
FDA-approved ursodiol capsules provided as prescription therapy with dosage options for prevention and treatment of gallstones.
Services
Program to engage independent and specialty pharmacies as preferred providers, including coordination of copay card details and provider-locator support.
Point of contact and engagement for businesses seeking partnership or commercial collaboration opportunities.
Online clinical education resources delivered via video/webinar on topics relevant to gastrointestinal therapy and product risk management.
Program to engage independent and specialty pharmacies as preferred providers, including coordination of copay card details and provider-locator support.
Point of contact and engagement for businesses seeking partnership or commercial collaboration opportunities.
Online clinical education resources delivered via video/webinar on topics relevant to gastrointestinal therapy and product risk management.
Expertise Areas
- Commercialization of FDA-approved gastrointestinal therapeutics
- Pharmacy network partnerships and preferred provider programs
- Healthcare professional education and clinical outreach
- Business development and external partnering
Key Technologies
- Digital distribution of prescribing information (PDF, regulatory links)
- Video/webinar-based clinical education
- Email and telephone partner communication channels